InMode Triton
Triple-wavelength diode · 755+810+1064nm Fusion
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- $100k–$135kSource not documented
- Used asking price
- $50k–$80kSource not documented
- FDA status
- Supplies & recurring costs
- See supply and replacement costs below.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 3 FDA records
K170738 (Inmode MD, Ltd., 2017)
The InMode Diolaze XL System is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K180719 (Inmode MD, Ltd., 2018)
The InMode Diolaze XL System with the Diolaze XL 810nm Hand piece is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The InMode Diolaze XL System with the Diolaze XL 755/810nm & 810/1064nm Hand pieces is intended for hair removal.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K173677 (Inmode MD, Ltd., 2018)
The InMode VLaze is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 8, 2026 · How we verify
Axis runs $0–$135k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | InMode |
|---|---|
| Company | Owner: Publicly traded (NASDAQ: INMD; no single controlling owner) (public company, since 2019) · Distribution: direct |
| Parent company | InMode |
| Brand owner | InMode |
| Built by (OEM) | InMode Ltd. |
| Category | Triple-wavelength diode |
| Technology | 755+810+1064nm Fusion |
| FDA status | FDA Cleared |
| 510(k) citation | K170738, K180719, K173677 |
| New price range | $100k–$135k |
| Used asking range | $50k–$80k |
| Consumables | Not published |
| Launch year | 2019 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Simultaneous 3-wavelength duo handpieces
How it worksTechnology and manufacturing
How the technology works
Fusion technology delivers two or three wavelengths (755nm alexandrite-type, 810nm diode, 1064nm Nd:YAG-type outputs from diode stacks) in a single simultaneous pulse — the theory being that blending absorption depths hits follicles at multiple anatomic levels (bulge and bulb) in one pass while spreading epidermal load.
Duo Light (755+810) optimizes finer/lighter hair on lighter skin; Duo Dark (810+1064) treats dark skin and tanned patients safely. Standard course 6-8 sessions; integrated cooling keeps comfort competitive.
Net: one room, one device, all Fitzpatrick types, all seasons.
Patented technology
"Fusion" simultaneous multi-wavelength emission — marketed at its 2018 launch as the world's first simultaneous multi-wavelength hair-removal platform; the blended-pulse delivery is the proprietary claim.
Origin
Yokneam, Israel (InMode) — same house as Morpheus8/BodyTite.
FDA & regulatory detailClearance timeline, authorization route and citation notes
Launch 2019 · Clearance 2026 · K170738; K180719; K173677
Platform clearance: FDA's device listing carries 'TRITON/OPTIMAS (system platform)' with the Diolaze XL (K170738, 7 Aug 2017; K180719 InMode Diolaze System, 14 Jun 2018) and VLaze/Vasculaze (K173677, 23 Feb 2018) applicators; no 510(k) naming Triton was located. Checked 8 Sep 2026.
FDA-cleared indications (verbatim)
K170738 (Inmode MD, Ltd., 2017)
The InMode Diolaze XL System is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K180719 (Inmode MD, Ltd., 2018)
The InMode Diolaze XL System with the Diolaze XL 810nm Hand piece is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The InMode Diolaze XL System with the Diolaze XL 755/810nm & 810/1064nm Hand pieces is intended for hair removal.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K173677 (Inmode MD, Ltd., 2018)
The InMode VLaze is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Triple-wavelength diode — 755+810+1064nm Fusion
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: InMode
Legal manufacturer: InMode Ltd. (Israel)
Applicant on the FDA record
InMode MD Ltd.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
None per treatment — no cryogen, no tips; lifecycle cost is diode handpiece life (pulse-count-driven refurb eventually, typically thousands — verify InMode's current handpiece exchange terms).
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published InMode Triton data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
ComplianceScreening and contraindications on the manufacturer's record
Contraindications & screening
Pregnancy (policy), photosensitizing drugs, active infection or open lesions, recent isotretinoin per policy; even with Duo Dark, fresh tans deserve conservative test spots; white/grey hair remains untreatable.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History13 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 8, 2026
FDA status
Unknown → Cleared
Source: Record correction
September 8, 2026
FDA K-numbers
K170738; K180719; K173677
Source: Record correction
September 8, 2026
FDA source URL
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K170738
Source: Record correction
September 4, 2026
contraindications
Manufacturer-conduct language removed or restated as a dated, sourced fact.
Source: Editorial sweep 2026-09-04: manufacturer-conduct language neutralized
September 4, 2026
Warranty & service
Unsourced evaluative sentence removed under the opinion-layer gate.
Source: Catalog update — Wave D opinion-layer gate, 2026-09-04
September 4, 2026
Warranty & service
Source: Editorial sweep 2026-09-04: unsourced opinion removed
September 4, 2026
FDA indication
Source: Catalog update
September 4, 2026
FDA status
No US 510(k) naming this model located; cleared assertion removed
Source: Council round 2 audit, verified on openFDA 2026-09-04
September 4, 2026
FDA status
Source: Catalog update
August 9, 2026
FDA status
Source: Catalog update
August 5, 2026
FDA status
Unknown → Cleared
Source: Catalog update
August 5, 2026
FDA indication
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "InMode Triton — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.